BDBM50082231 (2R,3S)-2-Benzo[b]thiophen-3-ylmethyl-3,N*4*-dihydroxy-N*1*-((S)-1-methylcarbamoyl-2-phenyl-ethyl)-succinamide::CHEMBL321288
SMILES: CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1csc2ccccc12)[C@H](O)C(=O)NO
InChI Key: InChIKey=SKXBXHXMSFHHJI-HBFSDRIKSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunoglobulin epsilon Fc receptor (Homo sapiens (Human)) | BDBM50082231 ((2R,3S)-2-Benzo[b]thiophen-3-ylmethyl-3,N*4*-dihyd...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibitory activity against IgE receptor | Bioorg Med Chem Lett 9: 3165-70 (1999) BindingDB Entry DOI: 10.7270/Q2MK6C37 | |||||||||||
More data for this Ligand-Target Pair |